Models predicting the prognosis of patients with PDA utilizing TRPM8 and related genes have been constructed, underscoring TRPM8’s pivotal pathogenic role in pancreatic tumors and its potential utility as molecular biomarkers and therapeutic targets in pancreatic cancer [44]. Here, TRPM8 is linked to Patent ductus arteriosus.